Latest News

"The European Commission approval of VIDAZA is recognition of the significant survival benefit afforded by this therapy for critical haematologic malignancies," said Philippe Van Holle, President of Celgene Europe. "We ...

That beats the coldest temperature recorded so far this season of -24.4 degrees set one month ago in canton Neuchâtel, the Swiss meteorological service has reported. Canton Ticino in southern ...

- First and Only Epigenetic Cancer Therapy Proven to Significantly Extend Survival for Patients with Intermediate-2 and Higher-Risk MDS and AML - First Approved Therapy Effective across Broad Range of ...

First and Only Epigenetic Cancer Therapy Proven to Significantly Extend Survival for Patients with Intermediate-2 and Higher-Risk MDS and AML First Approved Therapy Effective across Broad Range of MDS Subgroups, ...

MOFFETT FIELD, Calif. -- The Martian arctic soil that NASA's Phoenix Mars Lander dug into this year is very cold and very dry. However, when long-term climate cycles make the ...

PASADENA, Calif. -- After nearly a month of daily checks to determine whether Martian NASA's Phoenix Mars Lander would be able to communicate again, the agency has stopped using its ...

On 18–23 August, CERN hosted the 2008 edition of Strings, the annual conference that focuses on superstring theory and related matters. Ignatios Antoniadis and Wolfgang Lerche report. The annual “Strings” ...

MARK SCHWARZER: Moved to west London in the summer after spending 11 years at Middlesbrough, where he earned the title of most-capped foreigner at one club in English football. Now ...

Few headlines have been so dismally — but so spectacularly — incorrect as this. On the morning of July 16 1950, the early edition of Rio de Janeiro newspaper O ...

Celgene International Sarl (Nasdaq: CELG) has announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) ...